Butterfly Network Inc. (NYSE: BFLY), a digital health company pioneering portable ultrasound technology, saw its stock soar 5.31% on Wednesday after its third-generation handheld ultrasound device, Butterfly iQ3, was honored with the Best Medical Technology Award at the 2024 Prix Galien USA Awards.
The Prix Galien Awards, regarded as the "Nobel Prize of Life Sciences," recognize outstanding achievements in improving global human health through innovative drugs and treatments. Butterfly's recognition highlights the company's commitment to making ultrasound imaging more affordable, sustainable, and scalable through its pioneering Ultrasound-on-Chip technology.
The Butterfly iQ3 represents a leap forward in ultrasound technology, offering clinicians portable, semiconductor-based imaging with premium handheld quality. Built on Butterfly's proprietary P4.3 semiconductor – its most powerful Ultrasound-on-Chip platform to date – the iQ3 represents a digital revolution in the ultrasound industry, enabling practitioners to make faster, more accurate decisions, and ultimately transforming patient care on a global scale.
Comments